PROfound: Efficacy of olaparib (ola) by prior taxane use in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations | AVESİS

Istanbul University Research Information System

PROfound: Efficacy of olaparib (ola) by prior taxane use in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations

Copy For Citation

De Bono J. S., Fizazi K., Saad F., Shore N. D., Roubaud G., Ozguroglu M., ...More

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Costa Rica, 13 - 15 February 2020, vol.38

Publication Type: Conference Paper / Summary Text
Volume: 38
City: San-Francisco
Country: Costa Rica
Istanbul University Affiliated: Yes